Diabetes Board decisions

The Board has remanded the claims for service connection due to inadequate medical opinions and failure to consider all relevant evidence, including private medical records and x-rays.

The appeal for an effective date prior to July 14, 2000, for the award of 20 percent disabling of service-connected diabetes mellitus type II is dismissed because there was a concurrent election with another pending appeal.

The Veteran's combined rating of 90 percent based on past-due benefits granted in May 2024 is denied as the criteria for a higher rating have not been met.

The Board denied the Veteran's claims for earlier effective dates for service connection due to lack of evidence supporting a direct or presumptive basis for diabetes mellitus and diabetic neuropathy, as well as lack of herbicide exposure.

The Board has restored service connection for diabetes mellitus, diabetic retinopathy, and diabetic nephropathy, as well as special monthly compensation (SMC) (k), based on the Veteran's exposure to herbicide agents at Eglin Air Force Base.

The Board has remanded the case due to insufficient medical opinion regarding whether the Veteran's diabetes mellitus type II caused or contributed to his death. The VA examiner did not consider the Veteran's blood sugar levels on October 22, 2000, which were noted to be high and potentially life-threatening.

The Veteran's service-connected disabilities, including PTSD, CAD, diabetes, and related neuropathies, have rendered him unable to secure or follow a substantially gainful occupation. The Board has granted entitlement to Total Disability Rating Based on Individual Unemployability (TDIU) effective from October 26, 2020.

The Board has granted service connection for intraductal papillary mucinous neoplasm (IPMN) as secondary to the veteran's service-connected diabetes mellitus, type II (DM II). The decision is based on an approximate balance of positive and negative evidence.

The Veteran's claims for diabetes mellitus, type II and obstructive sleep apnea have been dismissed. Prior to January 20, 2020, the Veteran was denied a compensable rating for ventral diastasis. From January 20, 2020 onwards, he received a 10% rating for this condition.

The Board has dismissed the appeals for various ratings and effective dates due to the appellant's death.

The Veteran's claim for service connection for erectile dysfunction secondary to type two diabetes mellitus is granted with an effective date of October 1, 2020.

Effective June 29, 2021, the Veteran's diabetes mellitus, type II and hypothyroidism have been granted as secondary to Agent Orange exposure.,Effective June 29, 2021, the Veteran's diabetic neuropathy of various extremities and diabetic nephropathy are also granted as secondary to his diabetes mellitus, type II.

The Board has remanded the claims for service connection for diabetes mellitus, type II and hypertension as secondary to bilateral pes planus due to insufficient VA medical opinions addressing the Veteran's contentions.

The Veteran's claim for reimbursement of Beneficiary Travel mileage expenses to a Kansas City VAMC on December 11, 2023, is granted due to the travel being related to his service-connected disabilities and he was timely in filing his claim.

The Veteran's diabetes mellitus type II is presumed to be related to exposure to herbicide agents during his service aboard the USS Charles R. Ware, which was within 12 nautical miles of the Republic of Vietnam.

The Veteran's service connection claims for various conditions, including diabetes mellitus type 2, bilateral leg condition, bilateral foot conditions, and visual impairment (claimed as vision loss), were denied. The Board found no evidence to support a nexus between these conditions and the Veteran's military service.

The Veteran's appeal for a higher rating of his service-connected Diabetes Mellitus Type I with erectile dysfunction is dismissed because the Veteran did not identify a specific decision he disagrees with in his Notice of Disagreement.

The Veteran's service-connected disabilities do not result in the physical loss or permanent loss of use of one or both hands or feet, nor does it meet any other criteria for financial assistance in the purchase of an automobile or adaptive equipment. The Board denied the claim as there is no evidence of permanent loss of use of a hand or foot due to service-connected disability.

The Veteran's claims for service connection for diabetes mellitus, peripheral neuropathy of the upper and lower extremities are being remanded due to new evidence received since the last decision.,New evidence has been submitted regarding potential in-service chemical exposure leading to current conditions. The claim is being readjudicated.

The Board has granted service connection for diabetes mellitus type II (DMII) secondary to the Veteran's service-connected post-traumatic stress disorder (PTSD). The decision is based on a private medical opinion that concluded the PTSD caused obesity, which in turn led to DMII.